Global Cosmetic Grade Nicotinamide Mononucleotide Market Strategic Research Report

Scope of the Report

The global Cosmetic Grade Nicotinamide Mononucleotide market size is predicted to grow from US$ 11.62 million in 2025 to US$ 31.75 million in 2032; it is expected to grow at a CAGR of 15.7% from 2026 to 2032.

Cosmetic grade nicotinamide mononucleotide (NMN) is a niche but fast-growing part of both the NMN and cosmetic ingredients markets. In simple terms, NMN is a derivative of vitamin B3 and a direct precursor to NAD⁺, a molecule that cells use for energy, DNA repair, and many basic functions. When we talk about “cosmetic grade” NMN, we mean NMN that is produced and tested specifically for use on the skin, not for eating. Suppliers label it as “cosmetic grade, not food grade”, and sell it as a high-purity (usually ≥99%) active ingredient for use in creams, serums, masks and other skincare products.

From a market definition point of view, cosmetic grade NMN sits in the overlap of three areas: advanced cosmetic actives, NAD⁺-boosting “longevity” ingredients, and next-generation vitamin B3-type products. Many websites that sell cosmetic raw materials describe NMN as an “anti-aging superhero” ingredient that offers similar benefits to niacinamide (another B3 form) but with a stronger effect, such as helping moisturize the skin, strengthen the barrier, reduce wrinkles, brighten tone and improve hyperpigmentation. These claims are based on NMN’s biological role as a NAD⁺ precursor and on early research showing positive effects on skin cells and animal models, which has encouraged formulators to position NMN as a premium, science-based cosmetic active.

In 2024, global Cosmetic Grade Nicotinamide Mononucleotide production reached approximately 4.3 MT, with an average global market price of around US$ 2,479 per kg. The global single-line production capacity ranges from 0.5 to 1 MT per year. The industry's gross profit margin is approximately 30%-50%.

Market trends for cosmetic grade NMN are closely tied to the larger “longevity” and “science-based skincare” movements. Over the last few years, NAD⁺, NMN and related molecules have become popular in the wellness and longevity community, with large investments and heated scientific debates about how well these strategies actually work in humans. At the same time, beauty brands have been racing to add more “clinical” and “lab-tested” stories to their products. NAD⁺ skincare, which focuses on ingredients that maintain or raise NAD⁺ levels in skin cells, has begun to appear in fashion and lifestyle media as a new type of anti-aging approach. Cosmetic grade NMN fits directly into this trend, allowing brands to market themselves as sitting at the intersection of dermatology, anti-aging research and premium cosmetics.

Another strong driver is the need for differentiation in a very crowded anti-aging skincare market. Niacinamide, retinoids, vitamin C and peptides are now widely used and understood by consumers, which makes it harder for brands to stand out by using these ingredients alone. NMN, as a “next-generation B3” and NAD⁺ precursor, offers a fresh story. Suppliers highlight that NMN can offer all the typical niacinamide benefits (improving moisture, barrier function, tone and fine lines) with a “higher intensity” and extra support for cellular energy and repair. Because it is still relatively new, NMN gives brands the chance to launch hero products with unique messaging, higher price points, and a sense of cutting-edge innovation.

The rise of premium and dermocosmetic segments is also shaping this market. Many new NMN skincare launches position themselves as “clinical-grade,” “doctor-backed,” or “med-spa” style products, often combining NMN with other powerful actives such as peptides, hyaluronic acid, growth factors and retinoids. Cosmetic grade NMN is attractive in this context because it comes with high purity, clear documentation, and a technical data package that fits the expectations of dermatologists, aestheticians and advanced skincare consumers. Dermatology-style brands are also interested in NMN’s reported anti-inflammatory and barrier-supporting actions, which may be useful for sensitive, damaged or post-procedure skin.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cosmetic Grade Nicotinamide Mononucleotide market?

What factors are driving Cosmetic Grade Nicotinamide Mononucleotide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cosmetic Grade Nicotinamide Mononucleotide market opportunities vary by end market size?

How does Cosmetic Grade Nicotinamide Mononucleotide break out by Type, by Application?

This report presents a comprehensive overview of the global Cosmetic Grade Nicotinamide Mononucleotide market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Concentration≥98%
• Concentration＜98%

Segment by Production Method

• Enzymatic Synthesis
• Chemical Synthesis

Segment by Sales Channel

• Direct-to-consumer Online
• Offline Retail
• Professional Channel

Segment by Application

• Skin Care Products
• Facial Care Products
• Hair Care Products

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cosmetic Grade Nicotinamide Mononucleotide market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Skin Care Products, Facial Care Products, Hair Care Products evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact